Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Rieber

Showing results (141-150 of 150) with videos related to

Pageof 15
Sort By:
You have reached the last page of results.This site can display upto 150 results.
Deutsche Medizinische Wochenschrift (1946)|November 9, 1984
[Antibodies against human T-cell leukemia virus type III in acquired immunodeficiency syndrome and persistent lymphadenopathy]D Wernicke, K v d Helm, J Abb, et al.
International Journal of Cancer|October 23, 2001
Increased survivin transcript levels: an independent negative predictor of survival in soft tissue sarcoma patientsM Kappler, T Köhler, C Kampf, et al.
Journal of Virology|August 1, 1990
Infection of the human monocytic cell line Mono Mac6 with human immunodeficiency virus types 1 and 2 results in long-term production of virus variants with increased cytopathogenicity for CD4+ T cellsJ L'age-Stehr, M Niedrig, H R Gelderblom, et al.
Scandinavian Journal of Immunology|March 1, 1994
Treatment of rheumatoid arthritis with a chimeric CD4 monoclonal antibody (cM-T412): immunopharmacological aspects and mechanisms of actionP A van der Lubbe, C Reiter, A M Miltenburg, et al.
Leukemia|March 19, 2011
Simultaneous engagement of the activatory receptors NKG2D and CD3 for retargeting of effector cells to CD33-positive malignant cellsS Stamova, M Cartellieri, A Feldmann, et al.
Human Antibodies and Hybridomas|October 1, 1992
High-level expression and characterization of a mouse-human chimeric CD4 antibody with therapeutic potentialJ E Looney, D M Knight, M Arevalo-Moore, et al.
British Journal of Cancer|March 22, 2007
Identification of SOX2 as a novel glioma-associated antigen and potential target for T cell-based immunotherapyM Schmitz, A Temme, V Senner, et al.
Scandinavian Journal of Immunology|May 15, 2009
Detection of autoantibodies to tumour-associated antigens in sera of patients with systemic autoimmunity using a novel protein microblot arrayU Canzler, H Bartsch, S Ulitzsch, et al.
The American Journal of Pathology|June 11, 1999
A nonhuman primate model for the selective elimination of CD8+ lymphocytes using a mouse-human chimeric monoclonal antibodyJ E Schmitz, M A Simon, M J Kuroda, et al.
Science (New York, N.Y.)|February 5, 1999
Control of viremia in simian immunodeficiency virus infection by CD8+ lymphocytesJ E Schmitz, M J Kuroda, S Santra, et al.
Pageof 15

Showing results (141-150 of 150) with videos related to

Sort By:
Pageof 15
You have reached the last page of results.This site can display upto 150 results.
Deutsche Medizinische Wochenschrift (1946)|November 9, 1984
[Antibodies against human T-cell leukemia virus type III in acquired immunodeficiency syndrome and persistent lymphadenopathy]D Wernicke, K v d Helm, J Abb, et al.
International Journal of Cancer|October 23, 2001
Increased survivin transcript levels: an independent negative predictor of survival in soft tissue sarcoma patientsM Kappler, T Köhler, C Kampf, et al.
Journal of Virology|August 1, 1990
Infection of the human monocytic cell line Mono Mac6 with human immunodeficiency virus types 1 and 2 results in long-term production of virus variants with increased cytopathogenicity for CD4+ T cellsJ L'age-Stehr, M Niedrig, H R Gelderblom, et al.
Scandinavian Journal of Immunology|March 1, 1994
Treatment of rheumatoid arthritis with a chimeric CD4 monoclonal antibody (cM-T412): immunopharmacological aspects and mechanisms of actionP A van der Lubbe, C Reiter, A M Miltenburg, et al.
Leukemia|March 19, 2011
Simultaneous engagement of the activatory receptors NKG2D and CD3 for retargeting of effector cells to CD33-positive malignant cellsS Stamova, M Cartellieri, A Feldmann, et al.
Human Antibodies and Hybridomas|October 1, 1992
High-level expression and characterization of a mouse-human chimeric CD4 antibody with therapeutic potentialJ E Looney, D M Knight, M Arevalo-Moore, et al.
British Journal of Cancer|March 22, 2007
Identification of SOX2 as a novel glioma-associated antigen and potential target for T cell-based immunotherapyM Schmitz, A Temme, V Senner, et al.
Scandinavian Journal of Immunology|May 15, 2009
Detection of autoantibodies to tumour-associated antigens in sera of patients with systemic autoimmunity using a novel protein microblot arrayU Canzler, H Bartsch, S Ulitzsch, et al.
The American Journal of Pathology|June 11, 1999
A nonhuman primate model for the selective elimination of CD8+ lymphocytes using a mouse-human chimeric monoclonal antibodyJ E Schmitz, M A Simon, M J Kuroda, et al.
Science (New York, N.Y.)|February 5, 1999
Control of viremia in simian immunodeficiency virus infection by CD8+ lymphocytesJ E Schmitz, M J Kuroda, S Santra, et al.
Pageof 15